SAN FRANCISCO – DecisionView, Inc., the leading provider of business performance optimization applications for the Life Sciences industry, today announced the close of a $7 million Series C round of funding led by new investor, firstVentury, as well as existing investors Partech International and Granite Ventures.
"We are delighted to be working with firstVentury. Their experience with convergent technologies in Life Sciences and relationships with European companies makes them a logical partner for DecisionView," said Steve Andrade, CEO of DecisionView. "FirstVentury's participation validates our growing leadership in delivering innovative clinical performance optimization solutions that deliver tangible business results."
In addition to the funding, David Hartford, Managing Director, firstVentury, will be joining DecisionView's Board of Directors. "We are delighted to welcome David to our Board. His experience in the IT and Life Sciences technology domains will further complement the strength and contributions of our existing board members," continued Andrade.
"DecisionView epitomizes the convergence of IT and life science which firstVentury sees as an absolute necessity in bringing affordable new treatments to market rapidly," said David Hartford, managing director, firstVentury. "We are very pleased to be part of DecisionView's move to radically improve the clinical trials process."
The funding will be used to scale its commercial growth capabilities and expand DecisionView's suite of clinical performance optimization applications, including the company's innovative clinical recruitment platform, StudyOptimizerTM. As the industry's first business performance optimization application for clinical trials, StudyOptimizer automates the recruitment process with integrated predictive modeling, simulation, planning, and rich visualization capabilities. The company was also recently named in the list of "Cool Vendors" in the "Cool Vendors in Life Sciences, 2007" report by Gartner, Inc.
"DecisionView has made great strides in developing top-tier solutions to meet the demanding needs of the Life Sciences industry," said Tom McKinley, managing partner and co-founder, Partech International. "The company and its leading-edge technology are well-poised for significant growth."
"DecisionView has developed a terrific solution for life sciences companies, and this financing will allow the company to expand its reach in the market, as well as continue to innovate," said Granite Ventures managing director Chris Hollenbeck.
